Study | Reason for exclusion |
---|---|
21st Brazilian Diabetes Society Congressa | Congress report containing no studies of relevance |
Bin‐Abbas 2006 | Wrong study design: not a randomised clinical trial |
Bolli 2016 | Wrong study design: pooled data from four randomised clinical trials |
Chacra 2010 | Wrong intervention (applied basal insulin no longer available) |
Hirsch 2012 | Wrong study drug: compared insulin degludec/aspart combined with detemir + aspart (NCT00978627; NN5401‐3645; NN5401‐3645; Eudra: 2008‐005769‐71; U1111‐1111‐8943; 2009‐013412‐13; U1111‐1113‐2475) |
HypoANA | Wrong study drug: applied different type of rapid‐acting insulin analogue in the intervention arms |
Iga 2017 | Short duration of the intervention |
Kiess 2004 | Wrong study design: letter |
Manini 2007 | Wrong study design: not a randomised clinical trial |
NCT00788840 | Wrong population: people with T2DM |
NCT01854723 | Wrong population: people with insulin resistance |
Orchard 2014 | Wrong intervention: different co‐intervention |
Ota 2017 | Trial combined outcomes of people with T1DM and T2DM. No separate data available for the 12 people with T1DM included in the trial |
Perez‐Maraver 2013 | Applied different type of rapid‐acting insulin analogue in the intervention arms |
Polonsky 2014 | Wrong study design: not a randomised clinical trial |
Prikhodina 2007 | Wrong study design: not a randomised clinical trial |
Tentolouris 2018 | Wrong study design: not a randomised clinical trial |
UMIN000001562 | Wrong study design: one intervention arm |
UMIN000009965 | Study protocol for a study with short duration |
UMIN000013817 | Study protocol for a study with short duration |
Yamada 2014 | Short duration of the intervention |
Ziemen 2015 | Wrong intervention: comparing insulin glargine in different concentrations |
T1DM: type 1 diabetes mellitus T2DM: type 2 diabetes mellitus